Inventor · disambiguated record
Moshe Flashner-Barak
Also filed as: FLASHNER-BARAK MOSHE
11 granted patents·30 pending applications·199 citations·filing 2001–2016
91Inventor score
Top patents by PatentIndex Score
41 records- 0194US8663703B2Drug microparticles, processes of preparing them and a drug delivery vehicle comprising themLERNER E ITZHAK·Filed 2009·Granted Mar 4, 2014·62 cites·8 claims
- 0294US6881420B2Compositions and dosage forms for gastric delivery of irinotecan and methods of treatment that use it to inhibit cancer cell proliferationTEVA PHARMA·Filed 2001·Granted Apr 19, 2005·58 cites·25 claims
- 0389US6476006B2Composition and dosage form for delayed gastric release of alendronate and/or other bis-phosphonatesTEVA PHARMA·Filed 2001·Granted Nov 5, 2002·54 cites·42 claims
- 0488US8188067B2Formulations of 6-mercaptopurineLERNER E ITZHAK·Filed 2005·Granted May 29, 2012·9 cites·21 claims
- 0587US9375403B2Formulations of 6-mercaptopurineTEVA PHARMA·Filed 2015·Granted Jun 28, 2016·3 cites·15 claims
- 0686US8653060B2Formulations of 6-mercaptopurineLERNER E ITZHAK·Filed 2012·Granted Feb 18, 2014·5 cites·20 claims
- 0785US9180097B2Formulations of 6-mercaptopurineTEVA PHARMA·Filed 2014·Granted Nov 10, 2015·3 cites·12 claims
- 0879US9107832B2Risperidone microparticles formed by sublimationTEVA PHARMA·Filed 2014·Granted Aug 18, 2015·1 cites·8 claims
- 0973US6569459B2Method of administration of paclitaxel-plasma protein formulationTEVA PHARMA·Filed 2001·Granted May 27, 2003·4 cites·20 claims
- 1063US2006141051A1Drug microparticlesLERNER E I·Filed 2006·Application pending·0 cites
- 1163US2006141052A1Drug microparticlesLERNER E I·Filed 2006·Application pending·0 cites
- 1262US2006233879A1Controlled released dosage formsTEVA PHARMA·Filed 2006·Application pending·0 cites
- 1362US2006233880A1Controlled release dosage formsTEVA PHARMA·Filed 2006·Application pending·0 cites
- 1461US2005048086A1Compositions and dosage forms for gasteric delivery of antineoplastic agents and methods of treatment that use them to inhibit cancer cell proliferationFiled 2004·Application pending·0 cites
- 1559US2006141050A1Drug microparticlesLERNER ITZHAK E·Filed 2006·Application pending·0 cites
- 1658US2003224059A1Drug microparticlesFiled 2003·Application pending·0 cites
- 1757US10525009B2Formulations of 6-mercaptopurineHADASIT MED RES SERVICE·Filed 2016·Granted Jan 7, 2020·0 cites·9 claims
- 1855US2007178149A1Levodopa compositionsFLASHNER-BARAK MOSHE·Filed 2006·Application pending·0 cites
- 1953US2004122065A1Pharmaceutical compositions and dosage forms for buccal and sublingual delivery of tizanidine and methods of administering tizanidine sublingually or buccallyFiled 2003·Application pending·0 cites
- 2053US2005026871A1Method of increasing bioavailability of alendronate or other bis-phosphonate by predose administration of vitamin D derivativeFiled 2003·Application pending·0 cites
- 2152US2009042914A1Delayed release formulations of 6-mercaptopurineTEVA PHARMA·Filed 2008·Application pending·0 cites
- 2252US2006222706A1Formulations of FenofibrateFLASHNER-BARAK MOSHE·Filed 2005·Application pending·0 cites
- 2351US7579333B2Therapy using a combination of raloxifene and alendronateTEVA PHARMA·Filed 2005·Granted Aug 25, 2009·0 cites·21 claims
- 2451US2004092577A1Microparticle pharmaceutical compositions for intratumoral deliveryFiled 2003·Application pending·0 cites
- 2551US2004198646A1Menthol solutions of drugsFiled 2004·Application pending·0 cites
- 2649US2006141028A1Cyclosporin formulationsFLASHNER-BARAK MOSHE·Filed 2005·Application pending·0 cites
- 2749US2007148233A1Pharmaceutical formulations of fenofibrate having improved bioavailabilityLERNER E I·Filed 2005·Application pending·0 cites
- 2849US2006222707A1Formulations of fenofibrateLERNER E I·Filed 2006·Application pending·0 cites
- 2949US2007015834A1Formulations of fenofibrate containing PEG/PoloxamerFLASHNER-BARAK MOSHE·Filed 2005·Application pending·0 cites
- 3049US2007015833A1Formulations of fenofibrate containing mentholFLASHNER-BARAK MOSHE·Filed 2005·Application pending·0 cites
- 3147US2005170004A1Nanoparticles for drug deliveryFiled 2004·Application pending·0 cites
- 3247US2006153918A1Dosage forms with an enterically coated core tabletLERNER E I·Filed 2005·Application pending·0 cites
- 3347US2005113452A1Composition and dosage form for sustained effect of levodopaFiled 2004·Application pending·0 cites
- 3445US2005192340A1Simvastatin formulations and methods of making sameFiled 2004·Application pending·0 cites
- 3545US2006008520A1Delayed release formulations of 6-mercaptopurineLERNER E I·Filed 2005·Application pending·0 cites
- 3644US2003203878A1Composition and dosage form for delayed gastric release of alendronate and/or other bis-phosphonatesFiled 2003·Application pending·0 cites
- 3743US2007078174A1Tizanidine compositions and methods of treatment using the compositionsFLASHNER-BARAK MOSHE·Filed 2006·Application pending·0 cites
- 3840US2004052843A1Controlled release dosage formsFiled 2003·Application pending·0 cites
- 3939US2008057129A1Drug microparticlesLERNER E I·Filed 2007·Application pending·0 cites
- 4038US2002041888A1Method and composition for treating cancer by administration of apoptosis-inducing chemotherapeutic agentsFiled 2001·Application pending·0 cites
- 4138US2006018957A1Pharmaceutical dosage forms including rasagilineLERNER E I·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Moshe Flashner-Barak files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →